Keeping an Eye on Pacira BioSciences Inc (PCRX) After Insider Trading Activity

Daniel Torres

Pacira BioSciences Inc’s filing revealed that its Chief Financial Officer Cross Shawn unloaded Company’s shares for reported $0.4 million on Dec 09 ’25. In the deal valued at $25.03 per share,15,896 shares were sold. As a result of this transaction, Cross Shawn now holds 56,250 shares worth roughly $1.47 million.

Then, Cross Shawn sold 9,104 shares, generating $228,875 in total proceeds. Upon selling the shares at $25.14, the Chief Financial Officer now owns 56,250 shares.

Before that, Cross Shawn bought 9,104 shares. Pacira BioSciences Inc shares valued at $228,912 were divested by the Officer at a price of $25.14 per share.

Barclays initiated its Pacira BioSciences Inc [PCRX] rating to an Equal weight in a research note published on December 09, 2025; the price target was $27. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Truist also remained covering PCRX and has increased its forecast on July 25, 2025 with a “Buy” recommendation from previously “Hold” rating. Truist revised its rating on January 30, 2025. It rated PCRX as “a Hold” which previously was an “a Sell”.

Price Performance Review of PCRX

On Tuesday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock fall -1.87% to $26.18. Over the last five days, the stock has gained 5.69%. Pacira BioSciences Inc shares have risen nearly 32.22% since the year began. Nevertheless, the stocks have risen 38.96% over the past one year. While a 52-week high of $27.64 was reached on 09/03/25, a 52-week low of $18.17 was recorded on 01/06/25.

Levels Of Support And Resistance For PCRX Stock

The 24-hour chart illustrates a support level at 25.72, which if violated will result in even more drops to 25.26. On the upside, there is a resistance level at 26.90. A further resistance level may holdings at 27.62.

How much short interest is there in Pacira BioSciences Inc?

A steep rise in short interest was recorded in Pacira BioSciences Inc stocks on 2025-11-28, dropping by 61929.0 shares to a total of 7.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 7.28 million shares. There was a decline of -0.86%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.